Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 161 entries
View as:

PerAF: AF Termination vs Prespecified Ablation

Phase: N/A Priority: Normal
NCT ID: NCT06837441 Org: User:
Start: 01/01/23 End: 06/30/24 Due: 06/30/25

Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin

Phase: N/A Priority: Normal
NCT ID: NCT06698965 Org: User:
Start: 10/13/24 End: 10/31/29 Due: 10/31/30

Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients

Phase: N/A Priority: Normal
NCT ID: NCT03685669 Org: User:
Start: 06/01/17 End: 12/31/19 Due: 12/31/20

Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04684017 Org: User:
Start: 05/01/19 End: 01/01/22 Due: 01/01/23

Prediction Model of Peripheral Pulmonary Lesions Based on R-EBUS Image

Phase: N/A Priority: Normal
NCT ID: NCT04497233 Org: User:
Start: 07/01/18 End: 03/31/21 Due: 03/31/22

China Lung Cancer Screening (CLUS) Study Version 3.0

Phase: N/A Priority: Normal
NCT ID: NCT05494021 Org: User:
Start: 01/01/22 End: 12/31/26 Due: 12/31/27

Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT04473703 Org: User:
Start: 08/01/20 End: 08/01/23 Due: 08/01/24

ENB-GS-TBLB for the Diagnosis of PPLs

Phase: N/A Priority: Normal
NCT ID: NCT02207478 Org: User:
Start: 07/31/14 End: 04/30/15 Due: 04/30/16

Comparative Efficacy and Safety of Extensive Electro-Anatomical Guided Pulsed Field Ablation Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT06745167 Org: User:
Start: 01/01/25 End: 12/31/26 Due: 12/31/27

Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06904547 Org: User:
Start: 04/20/25 End: 12/31/30 Due: 12/31/31

RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs

Phase: N/A Priority: Normal
NCT ID: NCT06962436 Org: User:
Start: 05/31/25 End: 12/31/26 Due: 12/31/27

Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT04967079 Org: User:
Start: 08/01/21 End: 03/26/24 Due: 03/26/25

Toripalimab Combined with Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06127303 Org: User:
Start: 04/02/24 End: 04/02/28 Due: 04/02/29

Left Atrial Isolation by Catheter Ablation in Persistent Atrial Fibrillation With Severe Atrial Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05173779 Org: User:
Start: 01/01/23 End: 12/31/24 Due: 12/31/25

Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT06742866 Org: User:
Start: 12/16/24 End: 07/01/26 Due: 07/01/27

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

Phase: N/A Priority: Normal
NCT ID: NCT04814056 Org: User:
Start: 06/01/21 End: 01/31/24 Due: 01/31/25

Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）

Phase: N/A Priority: Normal
NCT ID: NCT05650216 Org: User:
Start: 12/25/22 End: 12/25/24 Due: 12/25/25

Comparison of Peri-procedural Complications of Intracardiac Echocardiography and Transesophageal Echocardiography in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT05466266 Org: User:
Start: 08/01/22 End: 08/01/23 Due: 08/01/24

mCBCT in Combination With ENB for the Diagnosis of PPNs

Phase: N/A Priority: Normal
NCT ID: NCT05518669 Org: User:
Start: 09/26/22 End: 06/30/24 Due: 06/30/25

ENB in the Diagnosis of Peripheral Pulmonary Nodules

Phase: N/A Priority: Normal
NCT ID: NCT03569306 Org: User:
Start: 07/04/18 End: 12/30/19 Due: 12/30/20

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT02951637 Org: User:
Start: 12/31/16 End: 12/31/19 Due: 12/31/20

Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04507906 Org: User:
Start: 11/02/20 End: 03/31/22 Due: 03/31/23

The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC

Phase: N/A Priority: Normal
NCT ID: NCT06965829 Org: User:
Start: 07/01/25 End: 07/01/28 Due: 07/01/29

Application of Mixed Reality Technique for Percutaneous Lung Nodule Localization: A Prospective, Randomized, Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT05715996 Org: User:
Start: 05/23/23 End: 03/31/24 Due: 03/31/25

Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

Phase: N/A Priority: Normal
NCT ID: NCT04382300 Org: User:
Start: 06/30/20 End: 04/30/23 Due: 04/30/24